Defiance Next Gen Altered Experience ETF
PSY
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- DE United States of America
- IPO Date
- May 27, 2021
- CIK
- 0001540305
- Similar Companies
- Business
- Defiance Next Gen Altered Experience ETF (NYSEARCA: PSY) is an exchange-traded fund that seeks to track the total return performance, before fees and expenses, of the BITA Medical Psychedelics, Cannabis, and Ketamine Index through a full replication strategy; it invests primarily in equity securities of life sciences companies conducting federally legal medical activities in the psychedelics, medical cannabis, hemp, and cannabidiol industries across the United States and Canada; the fund targets growth and value stocks of companies with diversified market capitalizations, including top holdings such as Cronos Group Inc., COMPASS Pathways plc, Atai Life Sciences N.V., and MindMed Inc.. Launched on May 27, 2021, and managed by Defiance ETFs LLC, a registered investment advisor founded in 2018 and headquartered in Miami, Florida, PSY operates with a net expense ratio of 0.75% and focuses on developed markets in North America, particularly targeting investors interested in emerging therapeutic sectors addressing mental health challenges like depression where traditional treatments show limitations.. As of late 2025, the fund manages approximately $5.04 million in assets under management amid ongoing innovation by its issuer, though no specific recent partnerships, acquisitions, funding rounds, or strategic shifts directly impacting PSY have been announced within the last 1-2 years; Defiance ETFs has instead pursued broader expansions, including multiple new leveraged and income ETF launches in 2025 such as the Daily Target 2X Long ETFs for stocks like MSTR (MSTX), SMCI (SMCX), and IONQ (IONX), partnerships like with Milliman for the YBMN Option Income ETF, and leveraged income products including AMDU and SMCC for AMD and Super Micro Computer..